Genotypes of neonatal inherited metabolic diseases in Zhejiang Provincefrom 2009 to 2021
YANG Rulai, SHEN Yaping, CHEN Chi, ZHOU Ying, XU Yanhua, SHU Qiang
Department of Genetics and Metabolism, Children's Hospital Affiliated to Zhejiang University School of Medicine(National Clinical Research Center for Child Health), Hangzhou, Zhejiang 310052, China
Abstract：Objective To investigate the genotypes and prognosis of infants with definitive diagnosis of inherited metabolic diseases during neonatal screening in Zhejiang Province from 2009 to 2021, so as to provide insights into the management of birth defects. Methods The medical records of infants with definitive diagnosis of inherited metabolic diseases by tandem mass spectrometry during neonatal screening in Zhejiang Province from 2009 to 2021 were collected from the database created by Zhejiang Provincial Center for Neonatal Disease Screening. The prevalence, genotypes and prognosis of inherited metabolic diseases were analyzed. Results A total of 1 038 infants were definitively diagnosed with inherited metabolic diseases in Zhejiang Province from 2009 to 2021, with an overall incidence rate of 1/4 535. There were 400 infants with amino acid metabolic disorders (AAD), 342 infants with fatty acid oxidation metabolic disorders and 296 infants with organic acid metabolic disorders (OAD), with incidence of 1/11 767, 1/13 763 and 1/15 902, respectively. There were 32 types of diseases, including 13 types of AAD, 8 types of FAOD and 11 types of OAD identified, and phenylketonuria and tetrahydrobiopterin deficiency (PKU/BH4D), primary carnitine deficiency (PCD) and methylmalonic academia (MMA) were detected as the most common forms of AAD, FAOD and OAD, with incidence of 1/20 827, 1/24 262 and 1/49 030, respectively. A total of 789 infants received genetic testing (76.01%), and genetic testing was performed among 70.00% of infants with AAD, 83.04% of infants with FAOD and 76.01% of infants with OAD. The c.728G >A (p.R243Q) variant was the most common mutation in infants with PKU (29.17%), c.1400C>G (p.S467C) variant was the most common mutation in infants with PCD (33.46%), c.609G>A (p.W203X) variant was the most common mutation in infants with combined MMA (40.00%), and c.1663G>A (p.A555T) variant was the most common mutation in infants with MMA (17.86%). Among the 997 infants (96.05%) with successful follow-up, 973 infants (93.74%) had normal intelligence and physical developments, and 41 infants died (3.95%), including 9 deaths due to AAD, 15 deaths due to FAOD and 17 deaths due to OAD. Conclusions The incidence of PKU, PCD and MMA was high among infants with inherited metabolic diseases in Zhejiang Province from 2009 to 2021, with c.728G>A (p.R243Q), c.1400C>G (p.S467C) and c.609G>A (p.W203X) variants as common gene mutations, respectively. Most infants with inherited metabolic diseases had a favorable prognosis; however, the mortality of OAD was relatively high.
[1] 赵正言,顾学范.新生儿遗传代谢病筛查 [M].北京:人民卫生出版社,2015. ZHAO Z Y,GU X F.Newborn genetic metabolic diseases screening[M].Beijing:People's Medical Publishing House,2015. [2] 龚易晓,宋晓红,徐娟,等.新生儿遗传代谢病串联质谱筛查病种探讨[J].中国公共卫生,2022,38(1):20-24. GONG Y X,SONG X H,XU J,et al.Neonatal genetic metabolic disease entities ought to be included in tandem mass spectrometry screening in China[J].Chin J Public Health,2022,38(1):20-24. [3] 刘齐,武红梅,刘翼飞,等.串联质谱在新生儿遗传代谢疾病筛查中的应用[J].中华检验医学杂志,2019,42(6):403-406. LIU Q,WU H M,LIU Y F,et al.Application of tandem mass spectrometry in newborn genetic metabolic disease screening[J].Chin J Lab Med,2019,42(6):403-406. [4] WILEY V,WEBSTER D,LOEBER G.Screening pathways through China,the Asia Pacific Region,the world [J/OL].Int J Neonatal Screen,2019,5(3)[2022-06-06].https://doi.org/10.3390/ijns5030026. [5] 全国妇幼卫生监测办公室,全国妇幼监测办公室.2017年中国新生儿遗传代谢病筛查信息报告[R].2017. [6] AHRING K,BELANGER-QUINTANA A,DOKOUPIL K,et al.Blood phenylalanine control in phenylketonuria:a survey of 10 European centres[J].Eur J Clin Nutr,2011,65(2):275-278. [7] 何江,杨曦,王瑞,等.西北五省区苯丙酮尿症患者苯丙氨酸羟化酶基因外显子12突变分析[J].中国优生与遗传杂志,2016,24(1):29-33. HE J,YANG X,WANG R,et al.Mutation analysis in exon 12 of the PAH gene in phenylketonuria patients of Northwest China[J].Chin J Birth Health Hered,2016,24(1):29-33. [8] 强荣,余伍忠,蔡娜,等.陕西地区苯丙酮尿症患儿苯丙氨酸羟化酶基因突变研究[J].中华医学遗传学杂志,2014,31(1):74-77. QIANG R,YU W Z,CAI N,et al.Mutations of the phenylalanine hydroxylase gene in phenylketonuria patients from Shaanxi[J].Chin J Med Genet,2014,31(1):74-77. [9] 何江,王惠珍,徐发亮,等.青海地区苯丙酮尿症患者苯丙氨酸羟化酶基因突变分析[J].中国当代儿科杂志,2015,17(11):1221-1227. HE J,WANG H Z,XU F L,et al.Mutation analysis of the PAH gene in children with phenylketonuria from the Qinghai area of China[J].Chin J Contemp Pediatr,2015,17(11):1221-1227. [10] 赖婷,李小洪,邓奎,等.2006—2016年中国新生儿疾病筛查覆盖率分析[J].中国妇幼保健杂志,2018,33(16):3601-3604. LAI T,LI X H,DENG K,et al.Analysis on neonatal screening coverage rate in China from 2006 to 2016[J].Matern Child Health Care China,2018,33(16):3601-3604. [11] CHEN T,XU W,WU D,et al.Mutational and phenotypic spectrum of phenylalanine hydroxylase deficiency in Zhejiang Province,China [J/OL].Sci Rep,2018,8(1)[2022-06-06].https://doi.org/10.1038/s41598-018-35373-9. [12] 吴德华,杨茹莱,郑静,等.原发性肉碱缺乏症的筛查、诊断、治疗及基因型研究[J].中国儿童保健杂志,2020,28(4):403-406. WU D H,YANG R L,ZHENG J,et al.Study on screening,diagnosis,treatment and genotype in primary carnitine deficiency[J].Chin J Child Health Care,2020,28(4):403-406. [13] 中华预防医学会出生缺陷预防与控制专业委员会新生儿遗传代谢病筛查学组,中华医学会儿科分会出生缺陷预防与控制专业委员会,中国医师协会医学遗传医师分会临床生化遗传专业委员会,等.原发性肉碱缺乏症筛查与诊治共识[J].中华医学杂志,2019,99(2):88-92. [14] 张振,季婵婵,董丽萍,等.新生儿甲基丙二酸血症筛查及随访分析[J].中国现代医生,2022,60(2):84-87,91. ZHANG Z,JI C C,DONG L P,et al.Screening and follow-up analysis of neonatal methylmalonic acidemia[J].China Mod Doct,2022,60(2):84-87,91. [15] 纪伟,田国力,王燕敏,等.上海部分地区新生儿遗传代谢病筛查和随访分析[J].中华新生儿科杂志,2021,36(2):10-15. JI W,TIAN G L,WANG Y M,et al.Newborn screening and prognosis of inherited metabolic disorders in Shanghai[J].Chin J Neonatol,2021,36(2):10-15. [16] 王丽雯,倪敏,贾晨路,等.应用串联质谱技术进行河南省新生儿甲基丙二酸血症的筛查结果分析[J].中国优生与遗传杂志,2019,27(7):846-848. WANG L W,NI M,JIA C L,et al.Analysis of screening results of mass spectrometry-mass spectrometry for neonatal methylmalonic academia in Henan Province[J].Chin J Birth Health Hered,2019,27(7):846-848. [17] 帅瑞雪,于玥,韩连书,等.cblB型甲基丙二酸血症患者临床表现基因变异及其预后分析(附4例报告)[J].中国实用儿科杂志,2020,35(11):891-895. SHUAI R X,YU Y,HAN L S,et al.Clinical data,genetic mutation and prognosis analysis of cblB type methylmalonic acidemia:a report of 4 patients[J].Chin J Pract Pediatr,2020,35(11):891-895. [18] 应艳琴,罗小平.新生儿遗传代谢病筛查与基因诊断的现状与展望[J].中华围产医学杂志,2021,24(2):85-88. YING Y Q,LUO X P.Screening and genetic diagnosis of neonatal inherited metabolic diseases:present and prospects[J].Chin J Perinat Med,2021,24(2):85-88. [19] TONG F,WANG J,XIAO R,et al.Application of next generation sequencing in the screening of monogenic diseases in China,2021:a consensus among Chinese newborn screening experts[J].World J Pediatr,2022,18(4):235-242. [20] 郑新灵,叶少燕,祝莎莎,等.台州市新生儿葡萄糖-6-磷酸脱氢酶缺乏症筛查资料分析[J].预防医学,2020,32(2): 187-189. ZHENG X L,YE S Y,ZHU S S,et al.Retrospective analysis of glucose-6-phosphate dehydrogenase deficiency in Taizhou newborns[J].Prev Med,2020,32(2): 187-189.
